Jones James bought CPIX
June 6, 2025 · Form 4 insider transaction
Jones James bought 8 shares of Cumberland Pharmaceuticals Inc. at $5.57 per share, a transaction worth $44.56. The trade was recorded as open-market purchase under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 35 days after the transaction.
Direction
Acquired (buy-side)
Shares
8
Price
$5.57
Total value
$44.56
InsiderJones James
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJune 6, 2025
Filing dateJuly 11, 2025
Shares owned after43,208
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024.